| Quarterly Financials | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
Revenue  | 832 | 888 | 901 | 998 | 994 | 1,043 | 1,111 | 1,312 | 1,367 | 1,346 | 1,410 | 1,576 | 1,711 | 1,914 | 1,944 |
| Expenses | 810 | 867 | 873 | 968 | 964 | 1,005 | 1,067 | 1,258 | 1,309 | 1,290 | 1,354 | 1,509 | 1,647 | 1,824 | 1,844 |
| EBITDA | 21 | 21 | 27 | 31 | 30 | 38 | 44 | 54 | 58 | 56 | 56 | 67 | 64 | 90 | 100 |
| Operating Profit % | 2 % | 2 % | 3 % | 3 % | 3 % | 3 % | 3 % | 3 % | 4 % | 4 % | 4 % | 4 % | 3 % | 5 % | 5 % |
| Depreciation | 5 | 7 | 6 | 6 | 6 | 7 | 7 | 8 | 8 | 9 | 9 | 10 | 10 | 15 | 12 |
| Interest | 13 | 13 | 14 | 18 | 16 | 17 | 10 | 12 | 10 | 11 | 11 | 12 | 14 | 17 | 21 |
| Profit Before Tax | 3 | 1 | 7 | 7 | 8 | 14 | 27 | 35 | 39 | 37 | 36 | 45 | 40 | 58 | 67 |
| Tax | -1 | 5 | 0 | 2 | 1 | -8 | 7 | 9 | 10 | 6 | 6 | 8 | 7 | 13 | 15 |
| Net Profit | 4 | -4 | 6 | 5 | 7 | 21 | 21 | 26 | 30 | 31 | 30 | 37 | 34 | 45 | 52 |
| EPS in ₹ | 8.67 | 1.49 | 15.18 | 3.24 | 4.21 | 5.73 | 4.62 | 5.43 | 5.85 | 5.91 | 6.39 | 7.26 | 6.35 | 6.44 | 8.77 |
Entero Healthcare Solutions
Entero Healthcare Solutions
1,764.90
-25.20
(-1.41%)
Market Cap
7,680.52 Cr
PE Ratio
46.53
Volume
1,20,363.00
Day High - Low
1,797.80 - 1,745.80
52W High-Low
1,920.00 - 944.00
Key Fundamentals
Market Cap
7,680.52 Cr
EPS
26.44
PE Ratio
46.53
PB Ratio
4.64
Book Value
386.51
EBITDA
285.20
Dividend Yield
0.00 %
Industry
Retail Sector
Pharmacy Retail Return on Equity
8.32
Debt to Equity
0.31
Analyst Rating and Forecast
- By Refinitiv from3 analysts
Actual
Company News
View All News
Entero Healthcare Solutions Ltd will hold a virtual group meeting with institutional investors on September 29, 2026, organized by Arihant Capital Markets.
Entero Healthcare shares flag large-trade signalSep 17, 2026
A large-trade signal flagged approximately 554,900 Entero Healthcare Solutions shares changing hands on NSE at ₹1,695, with a combined value of ₹94.06 crore across multiple trades.
Entero Healthcare Solutions Ltd disclosed that its subsidiary ACE Cardiopathy Solutions Private Limited was levied a penalty of ₹12,91,728 by the GST Authority in Uttar Pradesh. The penalty was imposed for non-generation of E-Invoice. The company paid the amount under protest to secure the immediate release of a vehicle and avoid further operational losses.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
654.00 | #1 7,856.96 | 37.06 | #1 6,963.80 | 12.60 | #1 220 | -21.51 | 41.25 | |
1,764.90 | #2 7,680.52 | #3 46.53 | #2 6,610.40 | #1 28.72 | #2 146 | #1 72.19 | 54.51 | |
70.00 | 199.31 | - | 9.20 | -4.17 | -2 | -166.67 | 35.07 | |
66.00 | 128.89 | #1 25.78 | 104.40 | 1.98 | 5 | - | 50.17 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
28.72 %
Net Income Growth
35.75 %
Cash Flow Change
225.15 %
ROE
37.07 %
ROCE
19.57 %
EBITDA Margin (Avg.)
4.87 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 749 | 836 | 1,126 | 1,309 | 2,345 | 2,703 | 3,600 |
| Fixed Assets | 186 | 189 | 262 | 268 | 289 | 559 | 958 |
| Current Assets | 552 | 636 | 851 | 1,023 | 2,011 | 2,076 | 2,508 |
| Capital Work in Progress | 2 | 2 | 1 | 0 | 0 | 0 | 3 |
| Investments | 0 | 0 | 0 | 0 | 0 | 58 | 130 |
| Other Assets | 561 | 645 | 863 | 1,041 | 2,056 | 2,085 | 2,510 |
| Total Equity & Liabilities | 749 | 836 | 1,126 | 1,309 | 2,345 | 2,703 | 3,600 |
| Current Liabilities | 269 | 291 | 462 | 624 | 602 | 845 | 1,588 |
| Non Current Liabilities | 56 | 58 | 101 | 87 | 102 | 87 | 260 |
| Total Equity | 424 | 487 | 563 | 598 | 1,641 | 1,770 | 1,753 |
| Reserve & Surplus | -16 | -32 | -62 | -73 | 1,593 | 1,676 | 1,639 |
| Share Capital | 439 | 517 | 4 | 4 | 44 | 44 | 44 |
Cash Flow
| Cash Flow | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Net Cash Flow | -23 | -11 | 14 | -21 | 122 | 82 | -82 |
| Investing Activities | -203 | -31 | -162 | -49 | -704 | 232 | -302 |
| Operating Activities | -37 | -69 | -35 | -45 | -37 | -77 | 96 |
| Financing Activities | 217 | 89 | 211 | 73 | 863 | -74 | 124 |
Share Holding
| % Holding | Sept 2023 | Feb 2024 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| Promoter | 78.85 % | 52.44 % | 52.44 % | 52.44 % | 52.44 % | 52.44 % | 52.42 % | 52.42 % | 52.42 % | 52.42 % | 52.42 % | 52.40 % |
| FIIs | 0.00 % | 0.00 % | 23.30 % | 23.32 % | 23.82 % | 22.21 % | 19.92 % | 17.20 % | 14.67 % | 5.14 % | 4.03 % | 4.37 % |
| DIIs | 0.00 % | 1.36 % | 2.28 % | 2.06 % | 7.73 % | 8.77 % | 9.64 % | 10.18 % | 9.65 % | 16.42 % | 16.62 % | 15.48 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 5.72 % | 4.95 % | 5.00 % | 4.06 % | 4.36 % | 5.41 % | 6.99 % | 9.36 % | 11.56 % | 12.25 % | 13.05 % |
| Others | 21.15 % | 40.48 % | 17.03 % | 17.18 % | 11.95 % | 12.23 % | 12.61 % | 13.20 % | 13.90 % | 14.46 % | 14.68 % | 14.70 % |
| No of Share Holders | 51 | 58 | 80,864 | 66,400 | 36,767 | 33,172 | 33,159 | 33,338 | 36,334 | 40,333 | 39,084 | 39,710 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 28 Aug 2024 |  Annual General Meeting | NA | 28 Aug 2024 | 1,245.00 | 1,301.20 |
| 12 Nov 2024 |  Quarterly Result Announcement | NA | 12 Nov 2024 | 1,387.70 | 1,477.80 |
| 12 Feb 2025 | Quarterly Result Announcement | NA | 12 Feb 2025 | 1,372.25 | 1,328.65 |
| 27 May 2025 | Quarterly Result Announcement | NA | 27 May 2025 | 1,443.60 | 1,477.30 |
| 08 Aug 2025 | Quarterly Result Announcement | NA | 08 Aug 2025 | 1,265.95 | 1,257.25 |
| 18 Sept 2025 | Annual General Meeting | NA | 18 Sept 2025 | 1,158.70 | 1,132.30 |
| 12 Nov 2025 | Quarterly Result Announcement | NA | 12 Nov 2025 | 1,111.35 | 1,089.00 |
| 12 Feb 2026 | Quarterly Result Announcement | NA | 12 Feb 2026 | 1,131.80 | 1,148.70 |
| 25 May 2026 | Quarterly Result Announcement | NA | 25 May 2026 | 1,192.80 | 1,354.40 |
| 07 Aug 2026 | Quarterly Result Announcement | NA | 07 Aug 2026 | 1,273.40 | 1,242.50 |
| 19 Aug 2026 | Annual General Meeting | NA | 19 Aug 2026 | 1,354.40 | 1,408.20 |
Announcements
Closure of Trading Window
6 days ago
6 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation7 days ago
7 days agoDisclosures under Reg. 29(2) of SEBI (SAST) Regulations 20117 days ago
7 days agoEntero Healthcare Solutions Limited Has Informed The Exchange About General Updates
Sep 12, 2026
Sep 12, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 26, 2026
Aug 26, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 24, 2026
Aug 24, 2026Announcement under Regulation 30 (LODR)-Change in ManagementAug 24, 2026
Aug 24, 2026Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 19, 2026
Aug 19, 2026Shareholder Meeting / Postal Ballot-Outcome of AGMAug 19, 2026
Aug 19, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 17, 2026
Aug 17, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 10, 2026
Aug 10, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 08, 2026
Aug 08, 2026Announcement under Regulation 30 (LODR)-Investor PresentationAug 07, 2026
Aug 07, 2026Unaudited Financial Results For The Quarter Ended June 30 2026.Aug 07, 2026
Aug 07, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On August 07 2026Aug 07, 2026
Aug 07, 2026Revised Intimation Of The Earnings CallAug 05, 2026
Aug 05, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 04, 2026
Aug 04, 2026Announcement under Regulation 30 (LODR)-AcquisitionJul 31, 2026
Jul 31, 2026Updated Annual Report Of The Company For The Financial Year 2025-26Jul 30, 2026
Jul 30, 2026Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results (Along With Limited Review Report) For The Quarter Ended June 30 2026.Jul 28, 2026
Jul 28, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 28, 2026
Jul 28, 2026Annual Report For The Financial Year 2025-26 Along With The Notice Convening The 8Th Annual General MeetingJul 27, 2026
Jul 27, 2026Intimation Regarding Dispatch Of Letters To Those Shareholders Whose Email Addresses Are Not Registered With Company/ Registrar And Share Transfer Agent/Depository Participant(S).Jul 27, 2026
Jul 27, 2026Business Responsibility and Sustainability Reporting (BRSR)Jul 27, 2026
Jul 27, 2026Reg. 34 (1) Annual Report.Jul 27, 2026
Jul 27, 2026Notice Convening The 8Th Annual General MeetingJul 27, 2026
Jul 27, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 23, 2026
Jul 23, 2026Announcement under Regulation 30 (LODR)-CessationJul 13, 2026
Jul 13, 2026Announcement under Regulation 30 (LODR)-Change in ManagementJul 13, 2026
Jul 13, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 06, 2026
Jul 06, 2026Announcement under Regulation 30 (LODR)-Change in ManagementJun 26, 2026
Jun 26, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJun 26, 2026
Jun 26, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On June 26 2026Jun 26, 2026
Jun 26, 2026Closure of Trading WindowJun 23, 2026
Jun 23, 2026Announcement under Regulation 30 (LODR)-Resignation of DirectorJun 12, 2026
Jun 12, 2026The Grant Of Fresh 17500 (Seventeen Thousand Five Hundred) Employee Stock Options Under The Existing Entero Employee Stock Option Plan 2023.Jun 11, 2026
Jun 11, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJun 11, 2026
Jun 11, 2026Board Meeting Outcome for Outcome Of Board MeetingJun 11, 2026
Jun 11, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJun 02, 2026
Jun 02, 2026Clarification On Investor Queries Relating To Profit Attributable To Owners Of The Company And Minority Interest For The Quarter Ended 31St March 2026May 28, 2026
May 28, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2026
May 27, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 27, 2026
May 27, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 26, 2026
May 26, 2026Announcement under Regulation 30 (LODR)-Investor PresentationMay 25, 2026
May 25, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 25, 2026
May 25, 2026The Board Approved The Re-Appointment Of Internal Auditor M/S. Ernst & Young LLP (EY) For The Next Financial Year 2026-27.May 25, 2026
May 25, 2026The Grant Of Fresh 7300 (Seven Thousand Three Hundred) Employee Stock Options Under The Existing Entero Employee Stock Option Plan 2023.May 25, 2026
May 25, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMay 25, 2026
May 25, 2026Announcement under Regulation 30 (LODR)-AcquisitionMay 25, 2026
May 25, 2026Announcement under Regulation 30 (LODR)-AllotmentMay 25, 2026
May 25, 2026Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 57.43
ATR(14)
Less Volatile 77.71
STOCH(9,6)
Neutral 78.64
STOCH RSI(14)
Neutral 32.75
MACD(12,26)
Bearish -16.04
ADX(14)
Strong Trend 37.75
UO(9)
Bearish 62.79
ROC(12)
Downtrend And Accelerating -2.09
WillR(14)
Neutral -42.01
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
